NCT06036758 - VIDAS® NEPHROCLEAR Diagnostic Accuracy Study | Biotech Hunter

Enrollment

477

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

December 28, 2023

Study Completion Date

December 28, 2023

Conditions

Acute Kidney InjuryStage 2 Acute Kidney InjuryStage 3 Acute Kidney Injury

Interventions

DIAGNOSTIC_TEST

VIDAS® NEPHROCLEAR™ CCL14 Test

Urine samples previously collected from persons with stage 2/stage 3 AKI will be tested using the VIDAS® NEPHROCLEAR™ CCL14 Test

Trial Locations (2)

George Washington University, Washington D.C.

University of Illinois, Chicago